Novel "CHASER" pathway for the management of pericardial disease

Critical Pathways in Cardiology

Volumn 10, Issue 2, 2011, Pages 57-63

  Argulian, Edgar ^a   Halpern, Dan G ^a   Aziz, Emad F ^a   Uretsky, Seth ^a   Chaudhry, Farooq ^a   Herzog, Eyal ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

clinical pathway; echocardiogram; pericardial disease; tamponade

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; CORTICOSTEROID; IBUPROFEN;

ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; DYSPNEA; ECHOCARDIOGRAPHY; HEALTH PROGRAM; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PERICARDITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYNCOPE; THORAX PAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC TAMPONADE; CARDIOVASCULAR AGENTS; CHEST PAIN; CLINICAL PROTOCOLS; CRITICAL PATHWAYS; DISEASE MANAGEMENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EVIDENCE-BASED PRACTICE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPOTENSION; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIUM; PROGRAM EVALUATION; SEVERITY OF ILLNESS INDEX;

EID: 79959902731     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e31821644bb     Document Type: Article

References (27)

1. Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25:587-610. (Pubitemid 38478552)
2. Herzog E, Shapiro J, Aziz EF, et al. Pathway for the management of survivors of out-of-hospital cardiac arrest. Crit Pathw Cardiol. 2010;9:49-54.
3. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363:717-727. (Pubitemid 38296562)
4. Spodick DH. Acute pericarditis: Current concepts and practice. JAMA. 2003; 289:1150-1153. (Pubitemid 37430329)
5. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: Results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012-2016. (Pubitemid 41377421)
6. Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995;75:378-382.
7. Permanyer-Miralda G. Acute pericardial disease: Approach to the aetiologic diagnosis. Heart. 2004;90:252-254. (Pubitemid 38250710)
8. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165:1987-1991. (Pubitemid 41362621)
9. Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med. 2004;351:2195-2202.
10. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: A management program for outpatient therapy. J Am Coll Cardiol. 2004;43:1042-1046. (Pubitemid 38352986)
11. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349:684-690. (Pubitemid 36976001)
12. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109:95-101.
13. Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore). 2003;82:385-391. (Pubitemid 37445042)
14. Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113:1622-1632. (Pubitemid 43739422)
15. Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: Evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380-1386. (Pubitemid 29451696)
16. Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003; 108:1852-1857. (Pubitemid 37296095)
17. Ling LH, Oh JK, Tei C, et al. Pericardial thickness measured with transesophageal echocardiography: Feasibility and potential clinical usefulness. J Am Coll Cardiol. 1997;29:1317-1323. (Pubitemid 27201952)
18. Haley JH, Tajik AJ, Danielson GK, et al. Transient constrictive pericarditis: Causes and natural history. J Am Coll Cardiol. 2004;43:271-275. (Pubitemid 38201155)
19. Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53: 157-163.
20. Chen Y, Brennessel D, Walters J, et al. Human immunodeficiency virusassociated pericardial effusion: Report of 40 cases and review of the literature. Am Heart J. 1999;137:516-521. (Pubitemid 29124121)
21. Gowda RM, Khan IA, Mehta NJ, et al. Cardiac tamponade in patients with human immunodeficiency virus disease. Angiology. 2003;54:469-474. (Pubitemid 36935361)
22. Eisenberg MJ, Oken K, Guerrero S, et al. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol. 1992;70:934-939.
23. Gillam LD, Guyer DE, Gibson TC, et al. Hydrodynamic compression of the right atrium: A new echocardiographic sign of cardiac tamponade. Circulation. 1983; 68:294-301. (Pubitemid 13028905)
24. Leimgruber PP, Klopfenstein HS, Wann LS, et al. The hemodynamic derangement associated with right ventricular diastolic collapse in cardiac tamponade: An experimental echocardiographic study. Circulation. 1983;68: 612-620. (Pubitemid 13050599)
25. Fusman B, Schwinger ME, Charney R, et al. Isolated collapse of left-sided heart chambers in cardiac tamponade: Demonstration by two-dimensional echocardiography. Am Heart J. 1991;121:613-616.
26. Merce J, Sagrista-Sauleda J, Permanyer-Miralda G, et al. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: Implications for the diagnosis of cardiac tamponade. Am Heart J. 1999;138:759-764. (Pubitemid 29471053)
27. Tsang TS, Freeman WK, Sinak LJ, et al. Echocardiographically guided pericardiocentesis: Evolution and state-of-the-art technique. Mayo Clin Proc. 1998;73:647-652.